Guilt-free sugary treats in the offing

Image
Press Trust of India Toronto
Last Updated : Jan 12 2016 | 6:02 PM IST
Guilt-free sugary treats may be on the horizon after scientists, including one of Indian-origin, have discovered an enzyme that can stop the toxic effects of sugar in various organs of the body.
The finding could lead to the development of therapeutics for obesity and type 2 diabetes, researchers said.
The enzyme, named glycerol 3-phosphate phosphatase (G3PP), plays a central role in controlling glucose and fat utilisation.
Led by Drs Marc Prentki and Murthy Madiraju, the research team at the University of Montreal Hospital Research Centre (CRCHUM) has demonstrated that G3PP is able to detoxify excess sugar from the cells.
"When glucose is abnormally elevated in the body, glucose-derived glycerol-3 phosphate reaches excessive levels in cells, and exaggerated glycerol 3 phosphate metabolism can damage various tissues," said Prentki, a professor at the University of Montreal.
"We found that G3PP is able to breakdown a great proportion of this excess glycerol phosphate to glycerol and divert it outside the cell, thus protecting the insulin producing beta cells of pancreas and various organs from toxic effects of high glucose levels," said Prentki.
Mammalian cells use glucose and fatty acids as the main nutrients. Their utilisation inside cells governs many physiological processes such as insulin secretion by beta cells, production of glucose in liver, storage of fat in adipose tissue and breakdown of nutrients for energy production.
Derangement of these processes leads to obesity, type 2 diabetes and cardiovascular diseases. The beta cells sense changes in blood glucose levels and produce insulin according to body demand.
Insulin is an important hormone for controlling glucose and fat utilisation. However, when beta cells are presented with excess glucose and fatty acids, the same nutrients become toxic and damage them, leading to their dysfunction and diabetes.
When glucose is being used in cells, glycerol-3-phosphate is formed, and this molecule is central to metabolism, since it is needed for both energy production and fat formation.
"By diverting glucose as glycerol, G3PP prevents excessive formation and storage of fat and it also lowers excessive production of glucose in liver, a major problem in diabetes," said Madiraju, a scientist at CRCHUM.
"It is extremely rare since the 1960s that a novel enzyme is discovered at the heart of metabolism of nutrients in all mammalian tissues, and likely this enzyme will be incorporated in biochemistry textbooks," Prentki said.
"We identified the enzyme while looking for mechanisms enabling beta cells to get rid of excess glucose as glycerol. This mechanism has also been found to be operating in liver cells, and this enzyme is present in all body tissues," Madiraju added.
The findings were published in the journal PNAS.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 12 2016 | 6:02 PM IST

Next Story